"Many people speculated that the SARAH study, reported today, was going to miss it's primary endpoint as the group of patients was too mixed."
Hi PB, can you give us a little more colour behind that statement? It's the first I've heard of it although I admit I'm not that close to the medical community.
Sirt result, page-5
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.003(1.64%) |
Mkt cap ! $65.79M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.5¢ | $1.707K | 11.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 288988 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2529183 | 21 |
View Market Depth
| Last trade - 10.59am 11/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |